March 2001
Biotech Business;Mar2001, Vol. 14 Issue 3, p6
Trade Publication
Reports that the United States Food and Drug Administration has approved the filing of an Abbreviated New Drug Application for a generic version of Claritin-D (R) by IMPAX Laboratories Inc.


Related Articles

  • Global Pharmaceuticals: Improving Health Through Technology.  // Drug Topics;Aug2014 Supplement, p16s 

    The article presents a corporate profile of generic pharmaceutical company Global Pharmaceuticals, the generic drug division of pharmaceutical firm Impax Laboratories Inc., in the U.S. It states that Global Pharmaceuticals brings value to its clients by furnishing them quality drugs for certain...

  • NEW GENERICS.  // Drug Topics;12/11/2006, Vol. 150 Issue 23, p89 

    The article presents a list of drugs with new generics including Pravastin from Genpharm, Inc. which is newly approved for the treatment of certain hyperlipidemias, and Colestipol hydrochloride tablets which will be marketed by Impax Laboratories, the new generic version of Colestid tablets from...

  • Impax Laboratories Schedules Conference Call and Webcast for 1st qtr 2011 Financial Results.  // Biomedical Market Newsletter;5/14/2011, p47 

    The article reports that it has been announced by Impax Laboratories, Inc. on April 14 2011 that its 1st quarter 2011 financial results will be released before the opening of the markets on May 3 2011 and will be available on Impax's Web site at http://www.impaxlabs.com. Impax Laboratories,...

  • NEW GENERICS.  // Drug Topics;7/9/2007, Vol. 151 Issue 13, p42 

    The article evaluates generic drugs, including alprazolam extended-release tablets from Impax Laboratories and oxybutynin chloride extended-release tablets from Teva Pharmaceuticals.

  • Impax Laboratories Announces Settlement of Litigation Relating to WELCHOL(r) Tablets and WELCHOL(r) Oral Suspension Products.  // Biomedical Market Newsletter;7/5/2011, p225 

    The article reports on the announcement of Impax Laboratories Inc. regarding the settlement of pending patent litigation with Daiichi Sankyo Inc. and Genzyme Corp. relative to the generic versions of WELCHOL products. It mentions that Impax Laboratories has been authorized to launch its product...

  • Global Pharmaceuticals: The Formulation Experts.  // Drug Topics;Aug2011, Vol. 155 Issue 8, p22s 

    The article profiles Global Pharmaceuticals, the generics division of technology-based specialty pharmaceutical company Impax Laboratories. It highlights two products marketed by Global Pharmaceuticals which include Fenofibrate Tablets and Doxycycline Capsules USP. It emphasizes the quality...

  • Impax Laboratories to Present at the Wells Fargo Securities Healthcare Conference.  // Biomedical Market Newsletter;6/19/2011, p109 

    The article reports on the announcement of Impax Laboratories Inc. that it will present at the 2011 Wells Fargo Securities Healthcare Conference held at the InterContinental in Boston, Massachusetts on June 23, 2011. It says that Impax Laboratories Inc. is a pharmaceutical company which applies...

  • Impax Laboratories Enters Into Development, Supply and Distribution Agreement with TOLMAR Inc.  // Biomedical Market Newsletter;6/30/2012, Vol. 21, p1 

    The article informs about collaboration between Impax Laboratories Inc. and Tolmar Inc. for development, supply and distribution of generic prescription drugs. It informs that as a part of the agreement, TOLMAR will be supplying up to nine currently approved and marketedproducts and Global...

  • Impax Laboratories to Present at the Jefferies 2011 Global Healthcare Conference Jefferies 2011 Global Healthcare Conference.  // Biomedical Market Newsletter;6/9/2011, p764 

    The article reports on the June 3, 2011 announcement by Impax Laboratories Inc. regarding its presentation at the Jefferies 2011 Global Healthcare Conference to be held at the Grand Hyatt Hotel in New York City on June 9, 2011. It says that people can listen to an archived or live presentation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics